It is also known that activation of the cGAS-STING pathway and simultaneous suppression of PD-L1 immunosuppressive factors effectively overcomes tumor resistance to radiotherapy and immunotherapy [52,53]. The gene discussed is CGAS; the disease is neoplasm.